Cesarean scar defects and abnormal uterine bleeding: a systematic review and meta-analysis

2022/08/17 by Ally Murji, Ari P. Sanders, Ilza Monteiro +8 · 26 citations
Medicine · #Maternal and Perinatal Health Interventions #Maternal and fetal healthcare #Pelvic floor disorders treatments

paper · doi:10.1016/j.fertnstert.2022.06.031

Citations

• Cesarean scar defect: a prospective study on risk factors

Cited by

• Prevalence of cesarean scar disorder in patients 3 years after a first cesarean section
• Investigating the impact of isthmocele and its surgical repair on fertility: results from a systematic review and meta-analysis
• Effectiveness of laparoscopic niche resection versus expectant management in patients with unexplained infertility and a large uterine caesarean scar defect (uterine niche): protocol for a randomised controlled trial (the LAPRES study). [europepmc]
• Mucinous Cystadenoma Arising in a Uterine Isthmocele: A Case Report. [europepmc]
• Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2. [europepmc]
• Clinical efficacy analysis of laparoscopic uterine artery pre-ligation combined with hysteroscopic curettage in the treatment of type II cesarean scar pregnancy. [europepmc]
• A transvaginal ultrasound-based diagnostic calculator for uterus post-cesarean scar defect. [europepmc]
• Value and influencing factors of preoperative MRI evaluation for previous cesarean scar defect associated abnormal uterine bleeding in patients undergoing laparoscopic surgery. [europepmc]
• Comparison of clinical effectiveness and subsequent fertility between hysteroscopic resection and vaginal repair in patients with cesarean scar defect: a prospective observational study. [europepmc]
• Clinical analysis of uterine parameters evaluated by preoperative magnetic resonance imaging in patients treated by hysteroscopic approach with previous cesarean scar defect-related abnormal uterine bleeding: a retrospective cohort study. [europepmc]
• Impact of cesarean scar defect on reproductive outcomes after assisted reproductive technology. [europepmc]
• Isthmocele and Infertility. [europepmc]
• Investigating the risk factors for isthmocele development after cesarean delivery. [europepmc]
• Abnormal uterine bleeding: The well-known and the hidden face. [europepmc]
• Association of caesarean scar defect with risk of abnormal uterine bleeding: results from meta-analysis. [europepmc]
• Prevalence and Clinical Features of Uterine Isthmocele Following Cesarean Sections: An Observational Study at Rabia Balkhi Hospital in Afghanistan. [europepmc]
• Hysteroscopic niche resection can effectively reduce the niche volume, increase residual myometrial thickness, and improve postmenstrual spotting symptoms. [europepmc]
• Two-layer interrupted versus two-layer continuous sutures for preventing cesarean scar defect: a randomized controlled trial. [europepmc]
• Improving Precision and Safety in Uterine Isthmocele Repair by Utilizing the KOH Cup and Firefly Guidance. [europepmc]
• Evaluation of the effectiveness of hysteroscopic myomectomy in the symptoms of women with uterine myomatosis: a retrospective cohort. [europepmc]
• Impact of previous cesarean delivery on reproductive outcomes of assisted reproductive technology: a Bayesian network meta-analysis. [europepmc]
• Single-versus double-layer uterine closure at the time of cesarean delivery and risk of uterine scar niche: a systematic review and meta-analysis of randomized trials. [europepmc]
• Development of the Er-Kay Classification: A Novel Volume-Based Assessment of Cesarean Scar Defects and Their Association with Abnormal Uterine Bleeding. [europepmc]
• The Contribution of CD26-Negative Fibroblasts to Endometrial Scarring. [europepmc]
• Impact of obstetric and surgical factors on isthmocele development: insights from a prospective cohort study. [europepmc]
• Cost-effectiveness of levonorgestrel intrauterine system versus hysteroscopic niche resection for caesarean scar-related spotting in China: an economic evaluation alongside a randomised controlled trial. [europepmc]